13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Testosterone in advance age: a New Zealand longitudinal cohort study: Life and Living in Advanced Age (Te Puāwaitanga o Ngā Tapuwae Kia Ora Tonu)

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objectives

          Serum testosterone (T) levels in men decline with age. Low T levels are associated with sarcopenia and frailty in men aged >80 years. T levels have not previously been directly associated with disability in older men. We explored associations between T levels, frailty and disability in a cohort of octogenarian men.

          Setting

          Data from all men from Life and Living in Advanced Age Cohort Study in New Zealand, a longitudinal cohort study in community-dwelling older adults.

          Participants

          Community-dwelling ( >80 years) adult men excluding those receiving T treatment or with prostatic carcinoma.

          Outcomes measures

          Associations between baseline total testosterone (TT) and calculated free testosterone (fT), frailty (Fried scale) and disability (Nottingham Extended Activities of Daily Living scale (NEADL)) (baseline and 24 months) were examined using multivariate regression and Wald’s χ 2 techniques. Subjects with the lowest quartile of baseline TT and fT values were compared with those in the upper three quartiles.

          Results

          Participants: 243 men, mean (SD) age 83.7 (2.0) years. Mean (SD) TT=17.6 (6.8) nmol/L and fT=225.3 (85.4) pmol/L. On multivariate analyses, lower TT levels were associated with frailty: β=0.41, p=0.017, coefficient of determination (R 2)=0.10 and disability (NEADL) (β=−1.27, p=0.017, R 2=0.11), low haemoglobin (β=−7.38, p=0.0016, R 2=0.05), high fasting glucose (β=0.38, p=0.038, R 2=0.04) and high C reactive protein (CRP) (β=3.57, p=0.01, R 2=0.06). Low fT levels were associated with frailty (β=0.39, p=0.024, R 2=0.09) but not baseline NEADL (β=−1.29, p=0.09, R 2=0.09). Low fT was associated with low haemoglobin (β=−7.83, p=0.0008, R 2=0.05) and high CRP (β=2.86, p=0.04, R 2=0.05). Relationships between baseline TT and fT, and 24-month outcomes of disability and frailty were not significant.

          Conclusions

          In men over 80 years, we confirm an association between T levels and baseline frailty scores. The new finding of association between T levels and disability is potentially relevant to debates on T supplementation in older men, though, as associations were not present at 24 months, further work is needed.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: not found

          Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study.

          We used longitudinal data from the Massachusetts Male Aging Study, a large population-based random-sample cohort of men aged 40-70 yr at baseline, to establish normative age trends for serum level of T and related hormones in middle-aged men and to test whether general health status affected the age trends. Of 1,709 men enrolled in 1987-1989, 1,156 were followed up 7-10 yr afterward. By repeated-measures statistical analysis, we estimated simultaneously the cross-sectional age trend of each hormone between subjects within the baseline data, the cross-sectional trend between subjects within the follow-up data, and the longitudinal trend within subjects between baseline and follow-up. Total T declined cross-sectionally at 0.8%/yr of age within the follow-up data, whereas both free and albumin-bound T declined at about 2%/yr, all significantly more steeply than within the baseline data. Sex hormone-binding globulin increased cross-sectionally at 1.6%/yr in the follow-up data, similarly to baseline. The longitudinal decline within subjects between baseline and follow-up was considerably steeper than the cross-sectional trend within measurement times for total T (1.6%/yr) and bioavailable T (2-3%/yr). Dehydroepiandrosterone, dehydroepiandrosterone sulfate, cortisol, and estrone showed significant longitudinal declines, whereas dihydrotestosterone, pituitary gonadotropins, and PRL rose longitudinally. Apparent good health, defined as absence of chronic illness, prescription medication, obesity, or excessive drinking, added 10-15% to the level of several androgens and attenuated the cross-sectional trends in T and LH but did not otherwise affect longitudinal or cross-sectional trends. The paradoxical finding that longitudinal age trends were steeper than cross-sectional trends suggests that incident poor health may accelerate the age-related decline in androgen levels.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Effects of Testosterone Treatment in Older Men.

            Serum testosterone concentrations decrease as men age, but benefits of raising testosterone levels in older men have not been established.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              An extended activities of daily living scale for stroke patients

                Bookmark

                Author and article information

                Journal
                BMJ Open
                BMJ Open
                bmjopen
                bmjopen
                BMJ Open
                BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
                2044-6055
                2017
                12 November 2017
                : 7
                : 11
                : e016572
                Affiliations
                [1 ]departmentFreemasons’ Department of Geriatric Medicine , University of Auckland , Auckland, New Zealand
                [2 ]departmentSchool of Population Health , University of Auckland , Auckland, New Zealand
                [3 ]departmentDepartment of Medicine , University of Otago , Christchurch, New Zealand
                [4 ]departmentGeriatric Medicine , Auckland District Health Board , Auckland, New Zealand
                [5 ]departmentCentre for Social Impact , Faculty of Business and Law, Swinburne University of Technology , Melbourne, Australia
                [6 ]University of Otago , Wellington, New Zealand
                Author notes
                [Correspondence to ] Professor Martin J Connolly; martin.connolly@ 123456waitematadhb.govt.nz
                Article
                bmjopen-2017-016572
                10.1136/bmjopen-2017-016572
                5695316
                29133315
                56a72151-5da8-4965-bb35-369ea495350d
                © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

                This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

                History
                : 28 February 2017
                : 06 August 2017
                : 09 August 2017
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100001505, Health Research Council of New Zealand;
                Categories
                Geriatric Medicine
                Research
                1506
                1698
                Custom metadata
                unlocked

                Medicine
                aged,disability,frailty,testosterone
                Medicine
                aged, disability, frailty, testosterone

                Comments

                Comment on this article